In pediatric gliomas, we recently described the generation of a high-grade astrocytoma model that recapitulates the genetics of a subset of tumors with mutated BRAFV600E and CDKN2A deletion. Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).